Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Oct 1;43(9):967-980.
doi: 10.1093/jpepsy/jsy029.

Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial

Luuk Stapersma  1 , Gertrude van den Brink  2 , Jan van der Ende  1 , Eva M Szigethy  3 , Ruud Beukers  4 , Thea A Korpershoek  4 , Sabine D M Theuns-Valks  5 , Manon H J Hillegers  1 , Johanna C Escher  2 , Elisabeth M W J Utens  1   6   7
Affiliations
Randomized Controlled Trial

Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial

Luuk Stapersma et al. J Pediatr Psychol. .

Erratum in

  • Corrigendum.
    [No authors listed] [No authors listed] J Pediatr Psychol. 2020 Aug 1;45(7):825. doi: 10.1093/jpepsy/jsy098. J Pediatr Psychol. 2020. PMID: 30500914 Free PMC article. No abstract available.

Abstract

Objective: To evaluate the effectiveness of a disease-specific cognitive behavioral therapy (CBT) protocol on anxiety and depressive symptoms and health-related quality of life (HRQOL) in adolescents and young adults with inflammatory bowel disease (IBD).

Method: A parallel group randomized controlled trial was conducted in 6 centers of (pediatric) gastroenterology. Included were 70 patients and young adults (10-25 years) with IBD and subclinical anxiety and/or depressive symptoms. Patients were randomized into 2 groups, stratified by center: (a) standard medical care (care-as-usual [CAU]) plus disease-specific manualized CBT (Primary and Secondary Control Enhancement Training for Physical Illness; PASCET-PI), with 10 weekly sessions, 3 parent sessions, and 3 booster sessions (n = 37), or (b) CAU only (n = 33). Primary analysis concerned the reliable change in anxiety and depressive symptoms after 3 months (immediate posttreatment assessment). Exploratory analyses concerned (1) the course of anxiety and depressive symptoms and HRQOL in subgroups based on age, and (2) the influence of age, gender, and disease type on the effect of the PASCET-PI.

Results: Overall, all participants improved significantly in their anxiety and depressive symptoms and HRQOL, regardless of group, age, gender, and disease type. Primary chi-square tests and exploratory linear mixed models showed no difference in outcomes between the PASCET-PI (n = 35) and the CAU group (n = 33).

Conclusions: In youth with IBD and subclinical anxiety and/or depressive symptoms, preliminary results of immediate post-treatment assessment indicated that a disease-specific CBT added to standard medical care did not perform better than standard medical care in improving psychological symptoms or HRQOL. ClinicalTrials.gov: NCT02265588.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
CONSORT study flowchart.
See this image and copyright information in PMC

References

    1. Alexakis C., Kumar S., Saxena S., Pollok R. (2017). Systematic review and meta-analysis: The impact of a depressive state on disease course in adult inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 46, 225–235. - PubMed
    1. Arrindell W. A. (2001). Changes in waiting-list patients over time: Data on some commonly-used measures. Beware!. Behaviour Research and Therapy, 39, 1227–1247. - PubMed
    1. Axelson D. A., Birmaher B. (2001). Relation between anxiety and depressive disorders in childhood and adolescence. Depression and Anxiety, 14, 67–78. - PubMed
    1. Beesdo K., Knappe S., Pine D. S. (2009). Anxiety and anxiety disorders in children and adolescents: Developmental Issues and Implications for DSM-V. The Psychiatric Clinics of North America, 32, 483–524. - PMC - PubMed
    1. Bennebroek Evertsz F., Sprangers M. A. G., Sitnikova K., Stokkers P. C. F., Ponsioen C. Y., Bartelsman J. F. W. M., van Bodegraven A. A., Fischer S., Depla A. C. T. M., Mallant R. C., Sanderman R., Burger H., Bockting C. L. H. (2017). Effectiveness of cognitive-behavioral therapy on quality of life, anxiety, and depressive symptoms among patients with inflammatory bowel disease: A multicenter randomized controlled trial. Journal of Consulting and Clinical Psychology, 85, 918–925. - PubMed

Publication types

Associated data